Evidence map›Paper›PMID 34589212›Full record

ReviewTherapeutic advances in infectious disease

Recognition and screening for Chagas disease in the USA.

Rachel Marcus, Andrés F Henao-Martínez, Melissa Nolan, Elizabeth Livingston, Stephen A Klotz, Robert H Gilman, Monica Miranda-Schaeubinger, Sheba Meymandi

Open access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. An Evidence-Based Intervention to IncreaseOpen forum infectious diseases · 2025
    Article
  3. Prevalence ofTropical medicine and infectious disease · 2024
    Article
  4. The epidemiology of Chagas disease in the Americas.Lancet regional health. Americas · 2024
    Review
  5. Article
  6. Review
  7. Current tropical medicine reports · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Rachel MarcusLASOCHA, MedStar Union Memorial Hospital, Baltimore, MD 21218-2829, USA.
Andrés F Henao-MartínezDivision of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID https://orcid.org/0000-0001-7363-8652
Melissa NolanArnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Elizabeth LivingstonDepartment of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Stephen A KlotzDivision of Infectious Diseases, University of Arizona, Tucson, AZ, USA.
Robert H GilmanDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Monica Miranda-SchaeubingerDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sheba MeymandiDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Johns Hopkins University · USDuke Medical Center · USMedStar Union Memorial Hospital · USUniversity of Arizona · USUniversity of California, Los Angeles · USUniversity of Colorado Anschutz Medical Campus · USUniversity of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease (CD), caused by the protozoan

Indexed as

Chagas diseasecongenital ChagasscreeningTrypanosoma cruziUSA

Identifiers

PMID34589212
PMCPMC8474340
OpenAlexW3201038649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.